fbpx UK takes the lead of the global fight against tubercolosis | Page 16 | Science in the net

UK takes the lead of the global fight against tubercolosis

Primary tabs

Read time: 1 min

One billion pounds. This is the sum pledged by the United Kingdom to the Global Fund to Fight AIDS, Tuberculosis and Malaria. With such a donation, Great Britain joined France and the European Nordic countries in the battle to defeat some of the world’s top infectious disease killers.

Tuberculosis (TB), in particular, is responsible for 9 million cases and 1.4 million deaths, almost all of which – 98 percent - occur in low and middle-income countries. The Global Fund provides almost 90 percent of all international financing for TB programmes, thus being the single largest and most important international donor for research programmes against tubercolosis in the World Health Organisation. Programmes that allowed to diagnose and treat 9.7 million individuals with TB.

The Global Fund is currently going through a ‘replenishment’ process this year, in order to raise funds from donors for the next three years (2014-2016) and will greatly benefit from UK’s significant contribution. Health organizations are now calling on the European Commission and European Union member states to join these efforts.

Autori: 
Sezioni: 
Infectious diseases

prossimo articolo

The Indi Gregory case: some questions for reflection

"The 'Indi Gregory Case' encompasses various levels of reflection (medical, ethical, legal, and political) that are interconnected but often confused in media debates. The philosopher of science and bioethicist Giovanni Boniolo analyzes them through a series of questions, the answers to which may also help us in similar cases that may arise in the future. Image: Twilight, by Dilma Freddi.

There has been, and continues to be, much talk about the "Indi Gregory Case." Indi was an eight-month-old baby suffering from a severe, and so far fatal, rare disease. More specifically, Indi was affected by D,L-2-hydroxyglutaric aciduria: a genetic disease with autosomal recessive inheritance caused by defects in the SLC25A1 gene.